Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Teva Pharmaceutical Industries Ltd

NYSE: TEVA · Life Sciences · 11 alerts · CIK 818686

Share price
$42.57Close, Nov 16
Market cap
$49.7B
Shares outstanding
1.17BLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Teva Pharmaceutical Industries Ltd filings on SEC EDGAR ↗

4:25 PM ET 8-K
Loan & Debt

Teva Pharmaceutical Industries $3.2B Debt Financing with The Bank of New York Mellon

Teva Pharmaceutical Industries issued a multi-tranche series of senior notes totaling $3.2 billion in USD-denominated notes and €1.5 billion in Euro-denominated notes. The proceeds are intended to fund the redemption of existing debt and for general corporate purposes, effectively refinancing the company's debt maturity profile.

Value
$3.2B
Counterparty
The Bank of New York Mellon
Term
through 2037

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.